1.Clinical analysis of 22 cases of bronchopleural fistula after pneumonectomy
Zhuangshi HUANG ; Huashan SHOU ; Canyu ZHANG
Clinical Medicine of China 1999;0(02):-
Objective To summarize the experience of the prevention and treatment on bronchopleural fistula (BF) complicated after pneumonectomy.Methods Clinical analysis of 22 cases of BF was retrospectively performed.Results The total incidence was 1.12%.The incidence of BF after total pneumonectomy was 1.7%,which was higher than that after pulmonary lobectomy (1.0%).The average time for the BF to occur was 13.8 days postoperatively.4 cases received operation again befroe healing occurred and 5 cases ended up in death (22.7%).Conclusion The key factors in preventing BF mainly lie in the suture techniques of bronchial residual stumps as well as the relevant factors influencing the healing.
2.Clinical diagnosis and treatment for recurrence and progress of relieved myasthenia gravis after thymecto-my
Xuguang WANG ; Kunpeng YANG ; Huashan SHOU ; Jin ZHANG ; Chengyu SHE
Clinical Medicine of China 2009;25(10):1073-1075
Objective To summarize the experience of clinical diagnosis and treatment for recurrence and progress of relieved myastbenia gravis after thymectomy. Methods 22 recurrent and progressive after relieved pa-tients with myasthenia gravis who underwent thymectomy were retrospectively analyzed. The remission therapy was conducted with combined glucocorticoid and anticholinesterase and its effectiveness was estimated. Results It was 1,17,4 as better Osserman scale Ⅰ , Ⅱ , Ⅲ respectively before operation but 15,6,1 as better Osserman scale Ⅱ , Ⅲ, Ⅳ respectively in recurrence and progress of relieved myasthenia gravis after thymectomy besides 6 with myas-thenic crisis. Complete remission and partial remission were gained in 9 patients and 12 patients respectively. There was 1 hospital-death. Conclusions Recurrence and progress can occur in any patient of relieved myasthenia gravis after thymectomy. Bulbar myasthenia gravis is usually presented as dysphagia. Reasonable administration of glucocor-tieoid could improve majority of recurrence and progress of relieved myasthenia gravis after thymectomy but responses poorly to the anticholinesterases.
3.Cohort study of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in China: evaluation of risk models and new predictor of pulmonary consolidation on computed tomography.
Yanhong SHOU ; Lu YANG ; Yongsheng YANG ; Xiaohua ZHU ; Feng LI ; Bo YIN ; Yingyan ZHENG ; Jinhua XU
Frontiers of Medicine 2021;15(4):585-593
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but severe diseases. This study aimed to validate the predictive ability of risk models in patients with SJS/TEN and propose possible refinement in China. Patients in the Department of Dermatology of Huashan Hospital from January 2008 to January 2019 were included. Results showed that the severity-of-illness score for TEN (SCORTEN) had a good discrimination (area under the receiver operating characteristic curve (AUC), 0.78), and it was superior to auxiliary score (AS) and ABCD-10, which indicates age, bicarbonate level, cancer, dialysis, and 10% involved body surface area (AUC, 0.69 and 0.68, respectively). The calibration of SCORTEN (Hosmer-Lemeshow goodness-of-fit test, P = 0.69) was also better than that of AS (P = 0.25) and ABCD-10 (P = 0.55). SCORTEN and ABCD-10 were similar (Brier score (BS), 0.04 and 0.04) in terms of accuracy of predictions. In addition, the imaging appearance of pulmonary consolidation on computed tomography was associated with high mortality. Refined models were formed using the variables and this imaging appearance. The refined AS and ABCD-10 models were similar in discrimination compared with the original SCORTEN (0.74 vs. 0.78, P = 0.23; 0.74 vs. 0.78, P = 0.30, respectively). Therefore, SCORTEN showed good discrimination performance, calibration, and accuracy, and refined AS or ABCD-10 model may be an option when SCORTEN variables are not available.
Cohort Studies
;
Humans
;
Retrospective Studies
;
Severity of Illness Index
;
Stevens-Johnson Syndrome/diagnostic imaging*
;
Tomography